BLISTER MANAGEMENT AND IMPACT ON FIREFIGHTERS
David Burns,
Senior Paramedic & Paramedic Practitioner
LifeAid, Victoria, Australia
RESEARCHER PROFILE
Filmed in Sydney, Australia | January 2025
David Burns, a Senior Paramedic with LifeAid, a private paramedicine company in Victoria and, has a diverse background in healthcare. He began his career as a registered nurse, progressing to critical care nursing specialising in liver transplants and cardiovascular surgery.
After serving on a rescue helicopter crew, he developed a passion for out-of-hospital healthcare, leading him to pursue paramedic training. Subsequently, he specialised in critical care and flight paramedicine, working in several regions in Australia including Victoria, Queensland, Western Australia, and in the United Kingdom.
David’s journey in private paramedicine led him to reconnect with Alan Close, the Managing Director of LifeAid. After contributing during the devastating 16-week bushfire period known as “Black Saturday”, David became passionate about community and primary care aspects of paramedicine and joined LifeAid in 2023.
At the Australasian College of Paramedicine International Conference, David presented research focused on the foot care of firefighters during prolonged bushfire campaigns. During the 2019-2020 bushfires, over 10,000 firefighters sought care, with nearly 50% requiring attention for foot-related issues. David emphasised that inadequate foot care could bench firefighters for up to 10 days, diminishing their ability to protect communities and critical infrastructure. Recognising the economic benefits of prioritising firefighter health, David advocates that ensuring their well-being allows communities to recover effectively and enhances safety for all involved in firefighting efforts.
You Might also like
- 
					
					World-first clinical trial improves patient outcomes for kidney transplants (2023)A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant. Around one in three people who receive a kidney transplant suffer delayed graft function, which means the transplant doesn’t work immediately and they require dialysis. The lead-author of the study, was Royal Adelaide Hospital Nephrologist and University of Adelaide researcher, Dr Michael Collins. 
- 
					
					Biological interactions of extracellular vesiclesRaluca Ghebosu graduated from the University of Queensland with a Bachelor of Arts/Bachelor of Science with majors in Japanese and Biomedical Science (2018-2021). She then completed her Bachelor of Science (Honours) with the School of Biomedical Sciences at the University of Queensland in 2022, before pursuing a PhD with A/Prof. Joy Wolfram at the Australian Institute for Bioengineering and Nanotechnology. 
- 
					
					Next generation nanomedicine and radiopharmaceuticals to treat cancerFinding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it. Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia. 
 
		
		 
					
																 
					
																